Genta Ishikawa, MD, MPH

My training as an academic pulmonologist in Japan and the US motivated me to seek new treatments for pulmonary fibrosis. After completing my medical training in my native country, I traveled to the US and earned an MPH degree at Emory University, to develop the skills required for conducting human research. Upon completing this degree, I then pursued clinical fellowship in Pulmonary, Critical Care, and Sleep Medicine at Mount Sinai Hospital, New York, where my clinical experience with pulmonary fibrosis – an incurable and fatal form of progressive interstitial lung diseases (ILDs) – inspired me to devote my career to developing new treatments for this condition. In pursuit of this goal, I started my postdoctoral fellowship at Yale in the laboratory of Dr. Erica Herzog, where I am currently working to translate a newly discovered neuro-innate fibrotic mechanism involving interactions between nerve derived noradrenaline and lung macrophages expressing alpha1 adrenoreceptors into treatments for pulmonary fibrosis.